Physitrack Future Growth

Future criteria checks 1/6

Physitrack is forecast to grow revenue at 19.6% per annum.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Healthcare Services earnings growth	18.3%
Revenue growth rate	19.6%
Future return on equity	n/a
Analyst coverage	Low
Last updated	22 Apr 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

OM:PTRK - Analysts future estimates and past financials data (EUR Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2026	27	N/A	N/A	N/A	1
12/31/2025	22	N/A	N/A	4	1
12/31/2024	18	N/A	N/A	5	1
12/31/2023	15	3	-1	3	N/A
9/30/2023	15	0	-2	2	N/A
6/30/2023	14	0	-2	2	N/A
3/31/2023	14	0	-3	2	N/A
12/31/2022	13	0	-3	1	N/A
9/30/2022	11	0	-3	1	N/A
6/30/2022	10	0	-3	0	N/A
3/31/2022	9	-1	-2	0	N/A
12/31/2021	8	-1	-1	1	N/A
11/30/2021	8	-1	-1	1	N/A
8/31/2021	6	-1	0	1	N/A
5/31/2021	5	1	1	2	N/A
2/28/2021	4	1	1	2	N/A
11/30/2020	3	1	1	2	N/A
11/30/2019	1	0	0	1	N/A
11/30/2018	1	0	N/A	N/A	N/A
11/30/2017	0	0	N/A	N/A	N/A
11/30/2016	0	0	N/A	N/A	N/A
11/30/2015	0	0	N/A	N/A	N/A
11/30/2014	0	0	N/A	N/A	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if PTRK's forecast earnings growth is above the savings rate (1%).

Earnings vs Market: Insufficient data to determine if PTRK's earnings are forecast to grow faster than the Swedish market

High Growth Earnings: Insufficient data to determine if PTRK's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: PTRK's revenue (19.6% per year) is forecast to grow faster than the Swedish market (1.7% per year).

High Growth Revenue: PTRK's revenue (19.6% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if PTRK's Return on Equity is forecast to be high in 3 years time

Physitrack Future Growth

Future criteria checks 1/6

Key information

Recent future growth updates

Consensus EPS estimates upgraded to €0.025 loss

Physitrack PLC Provides Earnings Guidance

Recent updates

Physitrack (STO:PTRK) Has A Somewhat Strained Balance Sheet

New minor risk - Earnings quality

Investor sentiment deteriorates as stock falls 18%

Full year 2023 earnings released: EPS: €0.20 (vs €0.006 in FY 2022)

Physitrack PLC (STO:PTRK) Could Be Riskier Than It Looks

Physitrack PLC, Annual General Meeting, May 03, 2024

Physitrack PLC to Report Q4, 2024 Results on Feb 28, 2025

New minor risk - Share price stability

Third quarter 2023 earnings released: €0.01 loss per share (vs €0.001 profit in 3Q 2022)

Revenues Tell The Story For Physitrack PLC (STO:PTRK)

Why Physitrack PLC (STO:PTRK) Could Be Worth Watching

Second quarter 2023 earnings released: €0.015 loss per share (vs €0.026 loss in 2Q 2022)

New minor risk - Share price stability

Physitrack plc Announces Board Changes

Physitrack PLC Announces Appointment of Jack Goodwin as Head of People

Physitrack PLC Approves Election of Anne-Sophie D'andlau as Director

First quarter 2023 earnings released

Independent Non-Executive Director recently bought kr56k worth of stock

Consensus EPS estimates upgraded to €0.025 loss

Full year 2022 earnings released: EPS: €0.01 (vs €0.06 loss in FY 2021)

Be Wary Of Physitrack (STO:PTRK) And Its Returns On Capital

Physitrack PLC Appoints Nick McClelland to Take on A New Role as Chief Growth Officer

High number of new and inexperienced directors

Physitrack PLC Announces the Appoints Anne-Sophie d'Andlau as Board Member

Third quarter 2022 earnings released: EPS: €0.001 (vs €0.07 loss in 3Q 2021)

Physitrack PLC to Report Q2, 2023 Results on Aug 15, 2023

Physitrack (STO:PTRK) Will Be Hoping To Turn Its Returns On Capital Around

Henrik Molin, Chief Executive Officer and Co-founder of Physitrack PLC acquired an additional 4.3% stake in Physitrack PLC (OM : PTRK) from Nathan Skwortsow, co-founder of Physitrack PLC for €1 million.

Second quarter 2022 earnings released: €0.02 loss per share (vs €0.011 loss in 2Q 2021)

Physitrack plc Recruits Announces Management Changes

Chief Operating Officer recently bought kr56k worth of stock

First quarter 2022 earnings: Revenues miss analyst expectations

Physitrack PLC (OM:PTRK) acquired Champion Health Ltd from Harry Bliss and Ricky Bailey for £10.4 million.

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

Chief Financial Officer recently bought kr62k worth of stock

Physitrack PLC (OM:PTRK) acquired Wellnow Group GmbH from Axel Springer Plug and Play Accelerator GmbH and Tengelmann Ventures Management GmbH for €11.5 million.

Physitrack PLC (OM:PTRK) acquired Wellnow Group GmbH from Axel Springer Plug and Play Accelerator GmbH and Tengelmann Ventures Management GmbH for €11.5 million.

Full year 2021 earnings: EPS exceeds analyst expectations

Physitrack PLC Provides Earnings Guidance

Investor sentiment improved over the past week

Physitrack PLC has completed an IPO in the amount of SEK 175 million.

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies